The front cover of the last Tissue Engineering A journal is Figure 6 of the SFB/TRR 225 joint paper of project C04:
Steiner D, Lingens L, Fischer L, Kohn K, Detsch R, Boccaccini AR, Fey T, Greil P, Weis C, Beier JP, Horch RE, Arkudas A, Encapsulation of Mesenchymal Stem Cells Improves Vascularization of Alginate-Based Scaffolds, Tissue Eng Part A 24(17-18) (2018) 1320-1331. (C03, C04, A01, B06, B03)
Vascularization of bioartificial tissues can be significantly enhanced by the generation of an arteriovenous (AV) loop. Besides the surgical vascularization, the choice of the scaffold and the applied cells are indispensable cofactors. The combination of alginate dialdehyde and gelatin (ADA–GEL) and mesenchymal stem cells (MSCs) is a promising approach with regard to biocompatibility, biodegradation, as well as de novo tissue formation. In this study, we targeted the investigation of the vascularization of ADA–GEL with and in the absence of encapsulated MSCs in the AV loop model. A Teflon chamber filled with ADA–GEL microcapsules was placed in the groin of Lewis rats and an AV loop was placed into the chamber. Group A encompassed the ADA–GEL without MSCs, whereas group B contained 2 × 106 DiI-labeled MSCs/mL ADA–GEL. Four weeks postoperatively, tissue formation and vascularization were investigated by histology and microcomputed tomography. We were able to prove vascularization originating from the AV loop in both groups with statistically significant more vessels in group B containing MSCs. Moreover, encapsulated MSCs promoted biodegradation of the ADA–GEL microcapsules. In the present study, we were able to demonstrate for the first time, the successful vascularization of ADA–GEL microcapsules by means of the AV loop. Furthermore, ADA–GEL displayed a good biocompatibility and encapsulation of MSCs into ADA–GEL microcapsule-enhanced vascularization as well as biodegradation.